DaVita HealthCare (DVA) Stock Slides as Market Rises: Facts to Know Before You Trade
In the latest trading session, DaVita HealthCare (DVA) closed at $142.16, marking a -0.53% move from the previous day.
Are Medical Stocks Lagging DaVita (DVA) This Year?
Here is how DaVita HealthCare (DVA) and Eledon Pharmaceuticals, Inc. (ELDN) have performed compared to their sector so far this year.
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should Value Investors Buy DaVita (DVA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to Note
DaVita HealthCare (DVA) closed the most recent trading day at $140.24, moving -1.39% from the previous trading session.
Why DaVita HealthCare (DVA) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
DaVita HealthCare (DVA) Stock Declines While Market Improves: Some Information for Investors
DaVita HealthCare (DVA) reachead $142.16 at the closing of the latest trading day, reflecting a -0.37% change compared to its last close.
DaVita (DVA) Gains 36% YTD: What's Driving the Stock Rally?
DaVita's (DVA) shares have risen year to date on the back of strong performance and the acquisition of dialysis centers.
Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway
“Price is what you pay; value is what you get.” In 2008, Warren Buffett told Berkshire Hathaway (NYSE: BRK-A , BRK-B ) shareholders that buying good businesses when they're cheap was the quintessential way to amass wealth.
DaVita, Nuwellis Extend Pilot Collaboration for Aquadex
DaVita DVA recently extended the pilot phase of a previously announced supply and collaboration agreement with Nuwellis NUWE until Aug 31, 2024.At the conclusion of the pilot phase, DaVita may extend the supply agreement with Nuwellis for continued provision of both inpatient and outpatient ultrafiltration services for up to 10 years.
5 Stocks to Gain as Service Side of the Economy Bounces Back
With service sector activity rebounding in recent times, it's worth placing bets on stocks such as CareCloud (CCLD), DaVita (DVA), RadNet (RDNT), SkyWest (SKYW) and American Express (AXP).
DaVita (DVA), Nuwellis Extend Pilot Collaboration for Aquadex
DaVita (DVA) extends its pilot collaboration with Nuwellis to conduct additional testing of the Aquadex ultrafiltration treatment for adult patients suffering from congestive heart failure and related conditions.
